Fresenius Medical Care and Aetna Collaborate to Provide Coordinated Care Management for End Stage Renal Disease Patients
June 10 2014 - 6:00AM
Business Wire
Program designed to improve clinical outcomes
for Aetna members with kidney failure while reducing overall cost
of care
Fresenius Medical Care (NYSE: FMS) and Aetna (NYSE: AET)
announced today a collaborative care model designed to improve the
quality of care for Aetna’s Medicare Advantage members who have end
stage renal disease, while lowering health care costs.
Fresenius Medical Care North America’s (FMCNA)
nationally-recognized care management program is accredited by the
National Committee for Quality Assurance, and creates a new
approach for the overall delivery of care focused squarely on the
unique needs of dialysis patients. Through this collaboration,
Aetna nurse case managers will work closely with FMCNA staff on
quality and care management for Aetna Medicare Advantage members
who are receiving care at an FMCNA clinic. Aetna and FMCNA will
work together to improve the health outcomes of these patients by
boosting adherence to best practices and treatment plans.
“We are proud to collaborate with Aetna and deliver the
resources and customized therapies necessary to improve the lives
of people living with end stage renal disease,” said Ron Kuerbitz,
Chief Executive Officer of Fresenius Medical Care North America.
“This collaboration embodies a truly integrated approach to serving
the full spectrum of health care needs for this vulnerable
population.”
“Aetna is committed to helping our Medicare members work with
their doctors to improve their quality of life by better managing
the conditions contributing to or resulting from chronic kidney
disease,” said Robert Mirsky, M.D., Aetna’s chief medical officer
for Medicare. “We value our collaboration with Fresenius Medical
Care and the complementary capabilities they can provide to improve
the care our members receive from them.”
This collaboration builds upon the relationship between
Fresenius Medical Care and Aetna, who continue to expand a joint
program to identify Aetna Medicare members with chronic kidney
disease, and provide education, training and care management
designed to ease what can be a difficult transition to dialysis or
pre-transplant care.
About Fresenius Medical Care North
America
Through its leading network of more than 2,150 dialysis
facilities in North America and vascular access centers,
laboratory, pharmacy and affiliated hospitals and nephrology
practices, Fresenius Medical Care provides renal services to
hundreds of thousands of people throughout the United States,
Mexico and Canada. It is also the continent's top producer of
dialysis equipment, dialyzers and related disposable products and a
major supplier of renal pharmaceuticals. For more information about
the company, visit www.fmcna.com; for information about patient
services, visit www.ultracare-dialysis.com.
About Aetna
Aetna is one of the nation's leading diversified health care
benefits companies, serving an estimated 44 million people with
information and resources to help them make better informed
decisions about their health care. Aetna offers a broad range of
traditional, voluntary and consumer-directed health insurance
products and related services, including medical, pharmacy, dental,
behavioral health, group life and disability plans, and medical
management capabilities, Medicaid health care management services,
workers' compensation administrative services and health
information technology products and services. Aetna's customers
include employer groups, individuals, college students, part-time
and hourly workers, health plans, health care providers,
governmental units, government-sponsored plans, labor groups and
expatriates. For more information, see www.aetna.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20140610005179/en/
Media contacts:Fresenius Medical CareJon Stone,
781-699-9704 (o)/781-392-4680
(cell)Jonthan.d.stone@fmc-na.comorAetnaKendall Marcocci,
717-540-6746 (o)/717-645-9496kmarcocci@cvty.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024
